-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.ISIN US046353AN82-
AstraZenecaBörse London Stock ExchangeISIN GB0009895292 WKN: 886455
-
AstraZeneca PLCBörse London Stock ExchangeISIN US046353AX64
-
AstraZeneca PLCBörse London Stock Exchange
-
ASTRAZENECA PLCBörse Börse StuttgartISIN US046353AU26Symbol ZEG
-
AstraZenecaBörse Xetra FrankfurtISIN US046353AQ14Symbol ZEG
-
ASTRAZENECA PLCBörse Gettex System der Börse MünchenSymbol ZEG
-
ASTRAZENECA PLCBörse Tradegate System der Deutsche Börse AG (60%)Symbol ZEG
-
ASTRAZENECA PLCBörse Quotrix System der Börse DüsseldorfSymbol ZEG
-
ASTRAZENECA PLCBörse Börse HamburgSymbol ZEG
-
ASTRAZENECA PLCBörse Börse DüsseldorfSymbol ZEG
-
AstraZeneca PLCBörse Xetra FrankfurtISIN US046353AR96
-
AstraZenecaBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"ISIN GB0009895292 WKN: 886455Symbol AZN
-
AstraZeneca PLCBörse Nasdaq
-
ISIN US046353AN82Symbol ZEG
-
ISIN US046353AS79Symbol ZEG
-
Symbol ZEG
-
AstraZeneca PLCBörse OMXSISIN US046353AZ13
-
Symbol AZN.LN
-
ISIN US046353AG32
-
AstraZeneca PLCBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US0463531089
-
EUR
-
AstraZeneca PLCBörse Freiverkehr OTC
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
137.591.537.664 oder 121.186.000.000 oder 129.298.078.520
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
70.600 oder 83.500 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
64.72 oder 73.9
Zahlte zuletzt am 25.02.2021 eine Dividende von 1,374 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Aktionärsstruktur der AstraZeneca PLC
Portrait der AstraZeneca Aktie
Das Unternehmen AstraZeneca PLC aus Großbritannien beschäftigt 77.050 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.
ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.
Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
731 News & Informationen zur AstraZeneca Aktie
Innate Pharma : Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress
Marseille, France, Sept. 02, 2021 — AstraZeneca to present new data on monalizumab in combination with durvalumab in a late-breaking abstract on COAST Phase 2 trial Innate Pharma SA today… | September 2, 2021
Helped by TSMC and Foxconn, BioNTech vaccines finally reach Taiwan
TAOYUAN — The first batch of BioNTech SE’s COVID-19 vaccine arrived in Taiwan on Thursday, helped by the involvement of two of the world’s most important tech…
Helped by tech giants, BioNTech vaccines finally reach Taiwan
TAOYUAN — The first batch of BioNTech SE’s COVID-19 vaccine arrived in Taiwan on Thursday, after months of heated political and diplomatic wrangling and helped…
Moderna seeks U.S. authorization for COVID-19 vaccine booster By Reuters
Moderna seeks U.S. authorization for COVID-19 vaccine booster
Glaxo (GSK), SK bioscience's COVID-19 Jab Enters Phase III Study
GlaxoSmithKline (GSK) and SK bioscience begin a phase III study on GBP510, the latter's COVID-19 vaccine candidate. The study will compare GBP510 agai…
Rigel Pharmaceuticals : Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious Diseases
SOUTH SAN FRANCISCO, Calif., Sept. 1, 2021 /PRNewswire/ — Rigel Pharmaceuticals, Inc. , today announced the publication of results from a Phase 2 clinical trial evaluating the safety of… | September 1, 2021
The Worldwide DNA Vaccines Industry Should Reach $11.5 Billion By 2026
DUBLIN, Sept. 1, 2021 /PRNewswire/ — The
North Korea Rejects Covid-19 Vaccine Doses
Pyongyang turned down roughly three million doses of China’s Sinovac, saying they should instead be sent to harder-hit countries.
Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline is Expected to Support Growth – Forecast to 2027
/PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By…
Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline Is Expected To Support Growth – Forecast To 2027
DUBLIN, Aug. 31, 2021 /PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form
European Airlines Weaker As EU, U.S. Try to Limit Transatlantic Travel By Investing.com
European Airlines Weaker As EU, U.S. Try to Limit Transatlantic Travel
S. Korean COVID-19 vaccine in late-stage test against AstraZeneca shot By Reuters
S. Korean COVID-19 vaccine in late-stage test against AstraZeneca shot
India's COVID-19 vaccine supply jumps, raising export hopes
Global vaccine sharing platform COVAX hopes India will restart foreign sales sooner than later.
5 Penny Stocks To Watch For September With Upcoming Events
These penny stocks could be in focus as we turn the page on a new month.
AstraZeneca mandates COVID-19 vaccinations for U.S. staff (NASDAQ:AZN)
AstraZeneca (AZN) will require COVID-19 vaccinations for its U.S.-based employees if they are returning to work or visiting customers, the company confirmed on Monday.“To safeguard…
Australian state warns COVID-19 hospitalisations to peak in October By Reuters
Australian state warns COVID-19 hospitalisations to peak in October
New Zealand's Auckland stays in lockdown, officials report Pfizer-linked death By Reuters
New Zealand's Auckland stays in lockdown, officials report Pfizer-linked death
Foxconn founder Terry Gou asks BioNTech to reserve 30 mn more Covid vaccines for Taiwan
Taiwan's quest to access the vaccine, jointly developed with Pfizer Inc, has dragged on for months, hampered by accusations from Taipei of political interference from Beijing, which claims the island as Chinese territory. Beijing has denied the allegations.
Foxconn founder asks BioNTech to reserve 30 million more vaccines for Taiwan
Terry Gou, the billionaire founder of major Apple Inc supplier Foxconn, has asked BioNTech SE to reserve 30 million doses of its COVID-19 vaccine for Taiwan, saying he had received a very good… | August 30, 2021
Innate Pharma : to Participate in Upcoming Investor Conferences
Marseille, France, Aug. 30, 2021 — Innate Pharma SA today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor… | August 30, 2021
RedHill Biopharma meldet Finanzergebnisse und operative Highlights für das zweite Quartal 2021
– Erzielung eines Rekordquartalsumsatzes von 21,5 Millionen US-Dollar für Q2/2021, ein Anstieg von 4,5 % gegenüber Q1/2021 trotz schwieriger Marktbedingungen;…
New Zealand reports first death linked to Pfizer COVID-19 vaccine By Reuters
New Zealand reports first death linked to Pfizer COVID-19 vaccine
PM Modi asks people to be careful, vigilant against pandemic in Mann Ki Baat
PM Modi also spoke about sports gaining importance in the country, with India winning a medal in hockey at the Tokyo Olympics after 41 years
Australia logs record COVID-19 cases, driven by New South Wales By Reuters
Australia logs record COVID-19 cases, driven by New South Wales
Mesoblast : Management Team
Management Team
Mesoblast has a highly experienced management team made up of individuals who have held senior positions in international pharmaceutical and… | August 28, 2021
Theranos didn’t stop the search for the next healthcare star
Investors still hold entrepreneurs to higher standards, but the taint has faded. ‘It’s a short half-life.’
India’s covid vaccine coverage tops 62.3 crore after 1 crore jabs on Friday
India's recovery rate was at 97.56%. Also, while 46,759 new cases were reported in the last 24 hours, the country’s active caseload was at 359,775
Endurant Capital Management LP Buys Cigna Corp, Icon PLC, Thermo Fisher Scientific Inc, Sells OrthoPediatrics Corp, AdaptHealth Corp, Sanofi SA
GuruFocus Article or News written by insider and the topic is about:
AstraZeneca : ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement in copper mobilisation from tissues (Form 6-K)
ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement in copper mobilisation from tissues
ALXN1840 demonstrated approximately three… | August 27, 2021
Blood clot risk much higher from Covid-19 than with vaccines
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc’s shots, according to a large UK…
Blood clot risk much higher from Covid-19 than with vaccines — UK study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.’s shots, according to a large U.K. study.
Amgen Represents Good Value Following Sell-Off
GuruFocus Article or News written by Nathan Parsh and the topic is about: A look at the company's most recent quarter and why I think the stock could be a good value.
BioNTech- und Pfizer-Aktien in Rot: BioNTech und Pfizer reichen weitere Daten zu Auffrischungsimpfung ein – Impfstoff für Lateinamerika
Das deutsche Unternehmen BioNTech und sein US-Partner Pfizer wollen weitere Daten für die Zulassung einer Auffrischungsimpfung gegen das Coronavirus bei der US-Arzneimittelbehörde FDA einreichen. 26.08.2021
Pfizer, BioNTech expand covid-19 vaccine manufacturing into Latin America
Deal would allow Brazil’s Eurofarma to produce at least 100 million doses annually for distribution in the region
Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates, Business News
Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates
GlobeNewswire
August 26, 2021
– Established three clinical collaborations with Merck to conduct global combination trials with pembrolizumab for three clinical-stage oncology candidates – For more information, please visit: https://investor.adagene.com. Safe Harbor Statement Internal Contact:Ami KnoeflerAdagene650-739-9952ir@adagene.com External Contact: Bruce…
Covid vaccination drive: India administers 60.38 crore jabs so far
While 46,164 new cases were reported in the last 24 hours, India’s active caseload was at 333,725.
AstraZeneca's Forxiga Approved In Japan For Chronic Kidney Disease – Quick Facts
(RTTNews) – British drug major AstraZeneca (AZN.L, AZN) announced Thursday that its Japan's Ministry of Health, Labour and Welfare has approved Fo…
AstraZeneca : Phase III Trial In Wilson Disease Meets Primary Endpoint
(RTTNews) – British drug major AstraZeneca (AZN.L, AZN) said that FoCus Phase III trial in Wilson disease showed ALXN1840 met the primary endpoint…
Top 2nd-Quarter Trades of Bernard Horn's Polaris Capital
GuruFocus Article or News written by James Li and the topic is about: Global-oriented value fund releases quarterly portfolio
Global Antidiabetic Drug Market Report 2021-2026 – Opportunities in New Innovations
/PRNewswire/ — The “Global Antidiabetic Drug Market (2021-2026) by Drug Type, Diabetic Type, Patient, Geography, Competitive Analysis and the Impact of…